IJGC Podcast

Robotic Surgery for Interval Cytoreduction in Advanced Ovarian Cancer with Walter Gotlieb

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Dr. Walter Gotlieb to talk about robotic surgery for interval cytoreduction in advanced ovarian cancer and his article, "Incorporating robotic surgery into the management of ovarian cancer after neoadjuvant chemotherapy" (https://ijgc.bmj.com/content/early/2019/10/09/ijgc-2019-000413), which is the Lead Article for the November 2019 issue of the International Journal of Gynecological Cancer. Dr. Gotlieb is Professor & Chief of ObGyn at the McGill-affiliated Jewish General Hospital in Montreal. He is past President of GOC, the Gyn-Onc Society of Canada, past Secretary Treasurer of IGCS, and completed 10 years as senior editor of the IJGC.

RACC Trial Updates with Henrik Falconer

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Henrik Falconer from Karolinska University Hospital to talk about the RACC trial. Dr. Falconer is the Head of Gynecological Oncology at Karolinska University Hospital in Sweden and the Principal Investigator for the RACC trial.

Uterine Transposition with Reitan Ribeiro

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Dr. Reitan Riberio from the Erasto Gertner Hospital in Brazil to talk about uterine transposition surgery.

Health Services Research in Gynecologic Oncology with Alexander Melamed

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Dr. Alexander Melamed from Columbia University to talk about health services research in gynecologic oncology. Dr. Melamed is an assistant professor in Columbia University’s Vagelos College of Physicians and Surgeons, and a gynecologic oncologist practicing at New York Presbyterian/Columbia University Irving Medical Center. His research seeks to improve cancer care by applying innovative study designs and analytic approaches to observational data.

Prehabilitation Programs in Gynecologic Oncology with Ester Miralpeix

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Dr. Ester Miralpeix from Hospital Del Mar to talk about prehabilitation programs in gynecologic oncology and her article, ""Role and impact of multimodal prehabilitation for gynecologic oncology patients in an Enhanced Recovery After Surgery (ERAS) program"" {https://ijgc.bmj.com/content/early/2019/08/30/ijgc-2019-000597), which is the Lead Article for the November 2019 issue of IJGC. Dr. Ester Miralpeix is currently working at Hospital del Mar, Barcelona as a gynecologist and as an Associate Professor at Universitat Autònoma de Barcelona. During her career, she has rotated in some leading cancer centers like University of Texas MD Anderson Cancer Center and Memorial Sloan Kettering Cancer Center. Dr. Miralpeiz has always been heavily involved in gynecologic cancer and the development of innovative strategies for improving patient care trough ERAS and Prehabilitation programs."

The Role of Immunotherapy in Gynecologic Cancers with Amir Jazaeri

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Dr. Amir Jazaeri from the MD Anderson Cancer Center to provide an introductory overview of the current state and future challenges for immunotherapy in gynecologic cancers. Dr. Jazaeri is a Professor and the Director of the Gynecologic Cancer Immunotherapy Program in the Department of Gynecologic Oncology and Reproductive Medicine at the University of Texas, MD Anderson Cancer Center. Since his recruitment to MD Anderson in 2014, he has established a broad base immunotherapy program for gynecologic cancers that include adoptive cell therapies and immune checkpoint inhibitor investigations. His other areas of research interest include innovative clinical trial designs and translational research for identification of novel immunotherapy targets for gynecologic cancers.

The CONTESSA/NEOCON Trial with Marie Plante

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Dr. Marie Plante to talk about the CONTESSA/NEOCON Trial and conservative management of cervical cancer. Dr. Plante has a major interest in minimally invasive surgical (MIS) approaches in the treatment of gynecologic cancers and in fertility-preserving surgery for young women with cervical cancer. Dr Plante is currently leading two important international trials the SHAPE trial and the Contessa trial and currently serves as the co-chair of the cervical cancer research network (CCRN) as part of the GCIG.

HCAHPS Scores and Gynecologic Oncology Outcomes with Joe Dottino

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Dr. Joe Dottino from the MD Anderson Cancer Center to talk about HCAHPS scores and gynecologic oncology outcomes. Dr. Joseph Dottino is in his final year of fellowship in gynecologic oncology at the University of Texas MD Anderson Cancer Center. His research interests include quality and safety in cancer care and cost-effectiveness in gynecologic oncology.

The Role of Normothermia In Gynecologic Oncology with Amanika Kumar

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Dr. Amanika Kumar from the Mayo Clinic to talk about the role of Normothermia in gynecologic oncology. Dr. Amanika Kumar, MD, is a gynecologic oncologist at Mayo Clinic. She researches ovarian cancer patient outcomes and quality of life with a focus on surgical outcomes, frailty, and sarcopenia.

New Classification of Unfavorable Risk Criteria for Endometrial Cancer with Scott Glaser

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Dr. Scott Glaser from City of Hope to talk about the the new classification of "Unfavorable Risk Criteria" for endometrial cancer. Be sure to read his article, "A proposal for a new classification of ‘unfavorable risk criteria’ in patients with stage I endometrial cancer," published in the September 2019 issue of IJGC. Dr. Glaser is a radiation oncologist at City of Hope in greater Los Angeles, California, where he specializes in brachytherapy. His primary clinical and research focus includes gynecologic cancer, prostate cancer, and breast cancer.